2024
Return-to-Play After Plasmodium falciparum Malaria in a Professional American Football Player
Mun J, Ryan E, Whalen J, Martin S. Return-to-Play After Plasmodium falciparum Malaria in a Professional American Football Player. JBJS Case Connector 2024, 14: e24.00457. PMCID: PMC11581430, DOI: 10.2106/jbjs.cc.24.00457.Peer-Reviewed Original ResearchPlasmodium falciparum malariaPersistent splenomegalyHigh-grade feverProfessional American football playersAmerican football playersFalciparum malariaFootball playersPatient's symptomsCollision sport athletesMalariaEmergency departmentReturn-to-playBlood smearsHospital admissionRisk of deconditioningSplenomegalyNoncontact activityPatientsSport athletesSymptomsWeeksPlasmodiumOn-fieldFeverSmears
2019
Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease
Afinogenova Y, Ruan J, Yang R, Kleytman N, Pastores G, Lischuk A, Mistry PK. Aberrant progranulin, YKL-40, cathepsin D and cathepsin S in Gaucher disease. Molecular Genetics And Metabolism 2019, 128: 62-67. PMID: 31358474, PMCID: PMC6864269, DOI: 10.1016/j.ymgme.2019.07.014.Peer-Reviewed Original ResearchConceptsEnzyme replacement therapyGaucher disease patientsYKL-40 levelsYKL-40Replacement therapyDisease patientsGaucher diseaseBone involvementHealthy controlsProgranulin levelsLong-term enzyme replacement therapyHigh serum YKL-40Cathepsin DSerum YKL-40 levelsGaucher disease mouse modelContribution of fibrosisLower progranulin levelsSerum YKL-40Chemokine ligand 18Disease mouse modelSevere bone involvementCathepsin SPersistent splenomegalyResidual splenomegalyGene array analysis
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply